Literature DB >> 15497961

Antitubercular sesterterpenes from the Thai sponge Brachiaster sp.

Saeng-ngam Wonganuchitmeta1, Supreeya Yuenyongsawad, Niwat Keawpradub, Anuchit Plubrukarn.   

Abstract

A new scalarane-type sesterterpene, 12-deacetoxyscalarin 19-acetate (2), and two naturally new derivatives of manoalide-type sesterterpenes, (E)- and (Z)-neomanoalide 24,25-diacetates (3 and 4), were isolated from the Thai sponge Brachiaster sp., along with five other known sesterterpenes: heteronemin (1), heteronemin acetate (5), 12-epi-19-deoxyscalarin (6), 12-deacetyl-12-epi-19-deoxyscalarin (7), and manoalide 25-acetate (8). The antitubercular and cytotoxic activities of all eight compounds were evaluated to reveal the potent activity of compounds 1, 2, 5, and 8. Among these, compound 2 showed an interesting bioactivity profile, in possessing potent antitubercular activity and being practically inactive in the cytotoxicity bioassay.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15497961     DOI: 10.1021/np0498354

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  11 in total

Review 1.  Marine pharmacology in 2003-4: marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2007-02-09       Impact factor: 3.228

Review 2.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

Review 3.  Structural and Chemical Biology of Terpenoid Cyclases.

Authors:  David W Christianson
Journal:  Chem Rev       Date:  2017-08-25       Impact factor: 60.622

4.  Structures and potential antitumor activity of sesterterpenes from the marine sponge Hyrtios communis.

Authors:  Jun Li; Lin Du; Michelle Kelly; Yu-Dong Zhou; Dale G Nagle
Journal:  J Nat Prod       Date:  2013-08-14       Impact factor: 4.050

5.  Cytotoxic sesterterpenoids from a sponge Hippospongia sp.

Authors:  Yu-Chia Chang; Shang-Wei Tseng; Li-Lian Liu; Yalan Chou; Yuan-Shing Ho; Mei-Chin Lu; Jui-Hsin Su
Journal:  Mar Drugs       Date:  2012-04-27       Impact factor: 6.085

6.  Heteronemin, a Spongean Sesterterpene, Induces Cell Apoptosis and Autophagy in Human Renal Carcinoma Cells.

Authors:  Szu-Ying Wu; Ping-Jyun Sung; Ya-Ling Chang; Shiow-Lin Pan; Che-Ming Teng
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

Review 7.  A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2010.

Authors:  Marc Schumacher; Mareike Kelkel; Mario Dicato; Marc Diederich
Journal:  Molecules       Date:  2011-06-30       Impact factor: 4.411

Review 8.  The Potential of Indonesian Heterobranchs Found around Bunaken Island for the Production of Bioactive Compounds.

Authors:  Katja M Fisch; Cora Hertzer; Nils Böhringer; Zerlina G Wuisan; Dorothee Schillo; Robert Bara; Fontje Kaligis; Heike Wägele; Gabriele M König; Till F Schäberle
Journal:  Mar Drugs       Date:  2017-12-07       Impact factor: 5.118

9.  Heteronemin, a marine natural product, sensitizes acute myeloid leukemia cells towards cytarabine chemotherapy by regulating farnesylation of Ras.

Authors:  Archana P Retnakumari; Shabna Anwar; Minakshi Saikia; Nikhil P Anto; Rashmi Mittal; Shabna Shah; Kavya S Pillai; Vinod S Balachandran; Vidya Peter; Reeba Thomas; Ruby John Anto
Journal:  Oncotarget       Date:  2018-04-06

10.  Heteronemin, a Marine Sesterterpenoid-Type Metabolite, Induces Apoptosis in Prostate LNcap Cells via Oxidative and ER Stress Combined with the Inhibition of Topoisomerase II and Hsp90.

Authors:  Man-Gang Lee; Yi-Chang Liu; Yi-Lun Lee; Mohamed El-Shazly; Kuei-Hung Lai; Shou-Ping Shih; Seng-Chung Ke; Ming-Chang Hong; Ying-Chi Du; Juan-Cheng Yang; Ping-Jyun Sung; Zhi-Hong Wen; Mei-Chin Lu
Journal:  Mar Drugs       Date:  2018-06-10       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.